Quark Pharmaceuticals Inc. Withdraws IPO Filing
NEW YORK, July 27 (Reuters) - Quark Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, said on Friday it was withdrawing its initial public offering filing, citing market conditions.